AMENDMENT NO. 1 TO AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT
Exhibit 10.21
AMENDMENT NO. 1
TO AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT
This AMENDMENT NO. 1 TO AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “New Amendment”) is made as of March 18, 2021, by and between Xxxxx Therapeutics Group, Inc., a Delaware corporation (“FTG”, together with all subsidiaries and affiliates hereinafter referred to as the “Company”), and Xxxxxx Xxxxxxxxx (the “Executive”) This New Amendment shall amend that certain AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT, dated as of March 12, 2021 (the “Prior Amendment”), by and between the Company and the Executive.
RECITALS
WHEREAS, the Prior Amendment amended that certain Employment Agreement, dated on or about December 7, 2020, by and between the Company and the Executive (the “Employment Agreement”); and
WHEREAS, the vesting commencement date set forth in the Prior Amendment was mis-stated due to an administrative error; and
WHEREAS, the parties desire to amend the Prior Amendment to reflect the true intention of the Company and the Executive, as set forth herein.
NOW, THEREFORE, for good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:
IN WITNESS WHEREOF, the undersigned hereby executes this New Amendment as of the date first above written.
XXXXX THERAPEUTICS GROUP, INC.
By: /s/ Xxxx Xxxxx
Name: Xxxx Xxxxx Title: CEO
EXECUTIVE:
/s/ Xxxxxx Xxxxxxxxx
Name: Xxxxxx Xxxxxxxxx